General Information of Drug Off-Target (DOT) (ID: OTU7LW2F)

DOT Name Epoxide hydrolase 3 (EPHX3)
Synonyms EH3; EC 3.3.2.10; Abhydrolase domain-containing protein 9
Gene Name EPHX3
Related Disease
Carcinoma ( )
Melanoma ( )
Prostate cancer ( )
Prostate carcinoma ( )
Prostate neoplasm ( )
Gastric cancer ( )
Gastric neoplasm ( )
Hereditary diffuse gastric adenocarcinoma ( )
UniProt ID
EPHX3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
3.3.2.10
Pfam ID
PF00561
Sequence
MPELVVTALLAPSRLSLKLLRAFMWSLVFSVALVAAAVYGCIALTHVLCRPRRGCCGRRR
SASPACLSDPSLGEHGFLNLKSSGLRLHYVSAGRGNGPLMLFLHGFPENWFSWRYQLREF
QSRFHVVAVDLRGYGPSDAPRDVDCYTIDLLLVDIKDVILGLGYSKCILVAHDWGALLAW
HFSIYYPSLVERMVVVSGAPMSVYQDYSLHHISQFFRSHYMFLFQLPWLPEKLLSMSDFQ
ILKTTLTHRKTGIPCLTPSELEAFLYNFSQPGGLTGPLNYYRNLFRNFPLEPQELTTPTL
LLWGEKDTYLELGLVEAIGSRFVPGRLEAHILPGIGHWIPQSNPQEMHQYMWAFLQDLLD
Function Catalyzes the hydrolysis of epoxide-containing fatty acids. Active in vitro against epoxyeicosatrienoic acids (EETs) including 8,9-EET, 9,10-EET, 11,12-EET and 14,15-EET and leukotoxin.
KEGG Pathway
Chemical carcinogenesis - receptor activation (hsa05207 )
Chemical carcinogenesis - reactive oxygen species (hsa05208 )
BioCyc Pathway
MetaCyc:ENSG00000105131-MONOMER

Molecular Interaction Atlas (MIA) of This DOT

8 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Carcinoma DISH9F1N Strong Altered Expression [1]
Melanoma DIS1RRCY Strong Biomarker [2]
Prostate cancer DISF190Y Strong Biomarker [3]
Prostate carcinoma DISMJPLE Strong Biomarker [3]
Prostate neoplasm DISHDKGQ Strong Posttranslational Modification [3]
Gastric cancer DISXGOUK Limited Biomarker [4]
Gastric neoplasm DISOKN4Y Limited Biomarker [4]
Hereditary diffuse gastric adenocarcinoma DISUIBYS Limited Biomarker [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Epoxide hydrolase 3 (EPHX3). [5]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Epoxide hydrolase 3 (EPHX3). [6]
Decitabine DMQL8XJ Approved Decitabine increases the expression of Epoxide hydrolase 3 (EPHX3). [4]
SNDX-275 DMH7W9X Phase 3 SNDX-275 increases the expression of Epoxide hydrolase 3 (EPHX3). [8]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of Epoxide hydrolase 3 (EPHX3). [10]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Epoxide hydrolase 3 (EPHX3). [9]
------------------------------------------------------------------------------------

References

1 Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas.Int J Cancer. 2011 Dec 15;129(12):2855-66. doi: 10.1002/ijc.25951. Epub 2011 Apr 1.
2 Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.Cancer Res. 2006 Jun 15;66(12):6080-6. doi: 10.1158/0008-5472.CAN-06-0157.
3 Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis.J Urol. 2007 May;177(5):1753-8. doi: 10.1016/j.juro.2007.01.010.
4 Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci. 2006 Jan;97(1):64-71.
5 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
6 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
7 Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci. 2006 Jan;97(1):64-71.
8 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
9 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
10 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.